Arcutis Biotherapeutics Stock Forecast - Simple Regression

Arcutis Biotherapeutics Additional Predictive Modules

Most predictive techniques to examine Arcutis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arcutis using various technical indicators. When you analyze Arcutis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. Simple Regression model is a single variable regression model that attempts to put a straight line through Arcutis Biotherapeutics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Arcutis Biotherapeutics Simple Regression Price Forecast For the 27th of January

Given 90 days horizon, the Simple Regression forecasted value of Arcutis Biotherapeutics on the next trading day is expected to be 29.01 with a mean absolute deviation of 1.88, mean absolute percentage error of 4.69, and the sum of the absolute errors of 114.73.

Arcutis Biotherapeutics Stock Forecast Pattern

Backtest Arcutis Biotherapeutics

Arcutis Biotherapeutics Price Prediction

Buy or Sell Advice

Arcutis Biotherapeutics Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Arcutis Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Arcutis Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Arcutis Biotherapeutics historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Arcutis Biotherapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arcutis Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 23.24 26.20 29.16 Details

Intrinsic Valuation Low Real High 19.40 22.36 28.82 Details

Bollinger Band Projection (param) Low Middle High 25.01 27.95 30.89 Details

Arcutis Biotherapeutics After-Hype Price Density Analysis

Arcutis Biotherapeutics Estimiated After-Hype Price Volatility

Arcutis Biotherapeutics Stock Price Outlook Analysis

Notes

Arcutis Biotherapeutics Hype Timeline

Arcutis Biotherapeutics is presently traded for 26.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Arcutis is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.12%. %. The volatility of related hype on Arcutis Biotherapeutics is about 0.0%, with the expected price after the next announcement by competition of 26.20. About 98.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.34. Arcutis Biotherapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Arcutis Biotherapeutics to cross-verify your projections. For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.

Arcutis Biotherapeutics Related Hype Analysis

Other Forecasting Options for Arcutis Biotherapeutics

For every potential investor in Arcutis, whether a beginner or expert, Arcutis Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Arcutis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Arcutis. Basic forecasting techniques help filter out the noise by identifying Arcutis Biotherapeutics' price trends.

Arcutis Biotherapeutics Related Equities

Risk & Return

Correlation

Arcutis Biotherapeutics Market Strength Events

Arcutis Biotherapeutics Risk Indicators

Story Coverage note for Arcutis Biotherapeutics

Arcutis Biotherapeutics Short Properties

Additional Tools for Arcutis Stock Analysis